| Study Facilities (n = 4) | Control Facilities (n = 4) | ||||
---|---|---|---|---|---|---|
 | PHASE Population Size 1 | Pre-Intervention % in Control 2 | Post-Intervention, % in Control 2 | PHASE Population Size 1 | Pre-Intervention % in Control 2 | Post- Intervention % in Control 2 |
SBP ≥ 140 | 72,895 | 83.5 | 84.0 | 54,652 | 81.7 | 82.4 |
LDL-c ≥ 130 | 67,099 | 90.2 | 91.5 | 49,355 | 90.1 | 91.4 |
A1c ≥ 9% | 48,464 | 90.9 | 91.0 | 38,497 | 90.3 | 90.7 |
SBP 130-139¶ | 72,895 | 61.1 | 62.8 | 54,652 | 60.7 | 62.6 |
LDL-c 100-129 | 67,099 | 71.8 | 75.3 | 49,355 | 71.7 | 75.5 |
A1c 7-8.9% | 48,464 | 60.5 | 58.8 | 38,497 | 60.0 | 58.1 |